@Article{Woroń2020,
journal="Lekarz POZ",
issn="2450-3517",
volume="6",
number="1",
year="2020",
title="Pregabalin and duloxetine in the treatment of neuropathic pain – why the use of off-label drugs is consistent with the standards of management and current medical knowledge",
abstract="Neuropathic pain is a symptomatic diagnosis. The cause of neuropathic pain may be known and is usually an infection or injury. However, its cause is very often unknown in neuropathic pain. Neuropathic pain is characterised by altered reactivity of neurons at many levels of the nervous system – from peripheral nerve fibres to the cerebral cortex. The choice of individual drugs should result from both the clinical picture of the disease, the location and intensity of pain, comorbidities and other drugs used by the patient. A significant proportion of drugs used in the treatment of neuropathic pain is used off-label; hence, it is important to make the patient aware of the role of antiepileptic and antidepressant drugs in the treatment of neuropathic pain.",
author="Woroń, Jarosław",
pages="59--66",
url="https://www.termedia.pl/Pregabalin-and-duloxetine-in-the-treatment-of-neuropathic-pain-why-the-use-of-off-label-drugs-is-consistent-with-the-standards-of-management-and-current-medical-knowledge,98,40453,1,1.html"
}